Mi-Helper, Inc. and ObvioHealth have teamed up to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, allowing patients to use the device from the comfort of their own homes while providing essential data on a real-world population in a real-world […]
